PubMed:33147282
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 260-263 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T2 | 718-721 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T3 | 1011-1021 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
| T4 | 1022-1038 | Body_part | denotes | white blood cell | http://purl.org/sig/ont/fma/fma62852 |
| T5 | 1034-1038 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T6 | 1294-1312 | Body_part | denotes | respiratory system | http://purl.org/sig/ont/fma/fma7158 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 1028-1033 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T2 | 1294-1312 | Body_part | denotes | respiratory system | http://purl.obolibrary.org/obo/UBERON_0001004 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 1254-1266 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 40-48 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 135-159 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 161-169 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 199-246 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 199-232 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T6 | 248-256 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T7 | 505-513 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T8 | 707-715 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T9 | 1254-1266 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T10 | 1278-1312 | Disease | denotes | diseases in the respiratory system | http://purl.obolibrary.org/obo/MONDO_0005087 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 78-79 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T2 | 108-109 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T3 | 264-269 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T4 | 451-452 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T5 | 722-727 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T6 | 846-852 | http://purl.obolibrary.org/obo/UBERON_0003100 | denotes | female |
| T7 | 854-855 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T8 | 993-994 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 1028-1033 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
| T10 | 1034-1038 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T11 | 1294-1312 | http://purl.obolibrary.org/obo/UBERON_0001004 | denotes | respiratory system |
| T12 | 1422-1423 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 352-354 | Chemical | denotes | RP | http://purl.obolibrary.org/obo/CHEBI_141419 |
| T2 | 868-870 | Chemical | denotes | RP | http://purl.obolibrary.org/obo/CHEBI_141419 |
| T3 | 981-983 | Chemical | denotes | RP | http://purl.obolibrary.org/obo/CHEBI_141419 |
| T4 | 1394-1401 | Chemical | denotes | arbidol | http://purl.obolibrary.org/obo/CHEBI_134730 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-77 | Sentence | denotes | Clinical characteristics of re-positive COVID-19 patients in Huangshi, China: |
| T2 | 78-107 | Sentence | denotes | A retrospective cohort study. |
| T3 | 108-315 | Sentence | denotes | A cluster of patients with coronavirus disease 2019 (COVID-19) underwent repeated positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA tests after they were discharged from the hospital. |
| T4 | 316-379 | Sentence | denotes | We referred to them as re-positive (RP) patients in this study. |
| T5 | 380-480 | Sentence | denotes | We aimed to describe the clinical characteristics of these patients in a retrospective cohort study. |
| T6 | 481-680 | Sentence | denotes | After being treated for COVID-19, the patients underwent 14 days of quarantine following their discharge from the Huangshi Hospital of Traditional Chinese Medicine and the Huangshi Hospital of Youse. |
| T7 | 681-768 | Sentence | denotes | Two additional sequential SARS-CoV-2 RNA tests were performed at the end of quarantine. |
| T8 | 769-853 | Sentence | denotes | The median age of the 368 patients was 51 years, and 184 (50%) patients were female. |
| T9 | 854-907 | Sentence | denotes | A total of 23 RP patients were observed at follow-up. |
| T10 | 908-1368 | Sentence | denotes | Using multivariate Cox regression analysis, risk factors associated with RP included a higher ratio of lymphocyte/white blood cell on admission (adjusted HR 7.038; 95% CI, 1.911-25.932; P = 0.0034), lower peak temperature during hospitalization (adjusted HR, 0.203; 95% CI, 0.093-0.443; P<0.0001), and the presence of comorbidities, particularly hypertension or chronic diseases in the respiratory system (adjusted HR, 3.883; 95% CI, 1.468-10.273; P = 0.0063). |
| T11 | 1369-1519 | Sentence | denotes | Antivirus treatment with arbidol was associated with a lower likelihood of re-positive outcomes (adjusted HR, 0.178; 95% CI, 0.045-0.709; P = 0.0144). |